
2.11 Delayed Data As of Nov 30 | ![]() Today’s Change | 0.70 Today|||52-Week Range 3.11 | +177.63% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Applied Therapeutics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +563.51% increase from the last price of 2.11.
The current consensus among 1 polled investment analysts is to Outperform stock in Applied Therapeutics Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.